This compound is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological disorders. Its structure is often leveraged in the design of compounds that interact with neurotransmitter receptors, making it valuable for studying and developing treatments for conditions like depression, anxiety, and Parkinson's disease. Additionally, its trifluoromethyl group enhances metabolic stability and bioavailability, which is crucial for optimizing drug candidates. Researchers also explore its potential in creating novel inhibitors for enzymes involved in disease pathways, contributing to advancements in medicinal chemistry.